Healthcare provider profile · identity verified

Eric Scott Lee, D.O.

Family Practice · TISHOMINGO, OK · NPI 1255562831

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	665	79
Amlodipine Besylate	Amlodipine Besylate	591	71
Lisinopril	Lisinopril	544	64
Losartan Potassium	Losartan Potassium	536	61
Synthroid	Levothyroxine Sodium	494	53
Omeprazole	Omeprazole	493	57
Pantoprazole Sodium	Pantoprazole Sodium	479	54
Metformin Hcl Er	Metformin Hcl	477	56
Rosuvastatin Calcium	Rosuvastatin Calcium	475	54
Ozempic	Semaglutide	450	50
Potassium Chloride	Potassium Chloride	429	63
Metoprolol Succinate	Metoprolol Succinate	398	43
Furosemide	Furosemide	336	49
Gabapentin	Gabapentin	326	46
Tamsulosin Hcl	Tamsulosin Hcl	307	41
Albuterol Sulfate Hfa	Albuterol Sulfate	299	50
Alcohol Swabs	Alcohol Antiseptic Pads	276	52
Hydrochlorothiazide	Hydrochlorothiazide	261	26
Fluticasone Propionate	Fluticasone Propionate	227	35
Jardiance	Empagliflozin	218	29
Montelukast Sodium	Montelukast Sodium	213	29
Clopidogrel	Clopidogrel Bisulfate	212	23
Carvedilol	Carvedilol	208	22
Trazodone Hcl	Trazodone Hcl	197	28
Eliquis	Apixaban	188	24
Meloxicam	Meloxicam	175	26
Wixela Inhub	Fluticasone Propion/Salmeterol	175	28
Simvastatin	Simvastatin	159	17
Sertraline Hcl	Sertraline Hcl	128	18
Duloxetine Hcl	Duloxetine Hcl	119	15
Metoprolol Tartrate	Metoprolol Tartrate	116	16
Diclofenac Sodium	Diclofenac Sodium	102	23
Spiriva Respimat	Tiotropium Bromide	101	11
Atenolol	Atenolol	95	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	87	suppressed
Baclofen	Baclofen	83	14
Azelastine Hcl	Azelastine Hcl	82	16
Bupropion Xl	Bupropion Hcl	82	11
Combivent Respimat	Ipratropium/Albuterol Sulfate	76	suppressed
Spironolactone	Spironolactone	75	11
Famotidine	Famotidine	70	11
Celecoxib	Celecoxib	69	11
Warfarin Sodium	Warfarin Sodium	68	suppressed
Allopurinol	Allopurinol	66	suppressed
Topiramate	Topiramate	66	suppressed
Finasteride	Finasteride	64	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	63	suppressed
Fenofibrate	Fenofibrate	63	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	59	25
Naproxen	Naproxen	55	suppressed
Clonidine Hcl	Clonidine Hcl	53	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	53	suppressed
Premarin	Estrogens, Conjugated	53	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	11
Xarelto	Rivaroxaban	52	suppressed
Nebivolol Hcl	Nebivolol Hcl	50	suppressed
Clonazepam	Clonazepam	49	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	49	suppressed
Tizanidine Hcl	Tizanidine Hcl	49	suppressed
Pregabalin	Pregabalin	48	suppressed
Citalopram Hbr	Citalopram Hydrobromide	47	suppressed
Alendronate Sodium	Alendronate Sodium	46	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	46	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	45	suppressed
Hydralazine Hcl	Hydralazine Hcl	44	suppressed
Pravastatin Sodium	Pravastatin Sodium	44	suppressed
Chlorthalidone	Chlorthalidone	43	suppressed
Novolog Flexpen	Insulin Aspart	43	suppressed
Nystatin	Nystatin	43	suppressed
Ondansetron Odt	Ondansetron	43	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	42	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	41	suppressed
Ketoconazole	Ketoconazole	41	11
Nifedipine Er	Nifedipine	41	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	40	suppressed
Ezetimibe	Ezetimibe	38	suppressed
Propranolol Hcl	Propranolol Hcl	38	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Valsartan	Valsartan	36	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	14
Memantine Hcl	Memantine Hcl	32	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	32	suppressed
Alogliptin	Alogliptin Benzoate	31	suppressed
Levetiracetam	Levetiracetam	31	suppressed
Sucralfate	Sucralfate	31	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	29	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	29	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	28	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	28	13
Ibuprofen	Ibuprofen	28	suppressed
Prednisone	Prednisone	28	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Amiodarone Hcl	Amiodarone Hcl	26	suppressed
Acyclovir	Acyclovir	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Testosterone	Testosterone	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Metformin Hcl	Metformin Hcl	23	suppressed
Sitagliptin	Sitagliptin	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Ranolazine Er	Ranolazine	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Lactulose	Lactulose	20	suppressed
Testosterone Cypionate	Testosterone Cypionate	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Betamethasone Valerate	Betamethasone Valerate	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	13
Sevelamer Carbonate	Sevelamer Carbonate	17	suppressed
Asmanex	Mometasone Furoate	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Pacerone	Amiodarone Hcl	15	suppressed
Saxagliptin Hcl	Saxagliptin Hcl	15	suppressed
Cephalexin	Cephalexin	14	13
Minoxidil	Minoxidil	14	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	14	11
Tramadol Hcl	Tramadol Hcl	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Colestipol Hcl	Colestipol Hcl	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Primidone	Primidone	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Bromocriptine Mesylate	Bromocriptine Mesylate	11	suppressed
Digoxin	Digoxin	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error